Robert F. Kennedy Jr.

And so everybody's going to be clear on that mission. And, you know... We think that we're going to make a huge difference in the first year, but over four years, we'll be able to correct the course.

And so everybody's going to be clear on that mission. And, you know... We think that we're going to make a huge difference in the first year, but over four years, we'll be able to correct the course.

And so everybody's going to be clear on that mission. And, you know... We think that we're going to make a huge difference in the first year, but over four years, we'll be able to correct the course.

And seven of the eight recent FDA commissioners have immediately gone to work for industry. The CDC, the longest reigning recent CDC director, Julie Gerberding, who dramatically increased the vaccine schedule and added billions of dollars a year in revenue to Merck, went over to become the president or the vice president of Merck. That is astounding. You know, and that's typical.

And seven of the eight recent FDA commissioners have immediately gone to work for industry. The CDC, the longest reigning recent CDC director, Julie Gerberding, who dramatically increased the vaccine schedule and added billions of dollars a year in revenue to Merck, went over to become the president or the vice president of Merck. That is astounding. You know, and that's typical.

And seven of the eight recent FDA commissioners have immediately gone to work for industry. The CDC, the longest reigning recent CDC director, Julie Gerberding, who dramatically increased the vaccine schedule and added billions of dollars a year in revenue to Merck, went over to become the president or the vice president of Merck. That is astounding. You know, and that's typical.

You see lower level division and branch chiefs in the agency. Also, you know, they, sort of the common course is that they work at the agency until their pensions vest expires. And then they move on to industry. So the last three or four years that they're at the agency, they're doing a lot of favors for industry and they're letting a lot of things go by.

You see lower level division and branch chiefs in the agency. Also, you know, they, sort of the common course is that they work at the agency until their pensions vest expires. And then they move on to industry. So the last three or four years that they're at the agency, they're doing a lot of favors for industry and they're letting a lot of things go by.

You see lower level division and branch chiefs in the agency. Also, you know, they, sort of the common course is that they work at the agency until their pensions vest expires. And then they move on to industry. So the last three or four years that they're at the agency, they're doing a lot of favors for industry and they're letting a lot of things go by.

And they want a soft landing at one of these companies. Mm-hmm. And their example then drives the – it infiltrates all the lower strata of the agency because they see the boss doing this. And they think this is the way that it's done. And you get punished for not going along. But there's a hundred other mechanisms for agency capture. And those come from appropriations through the Congress.

And they want a soft landing at one of these companies. Mm-hmm. And their example then drives the – it infiltrates all the lower strata of the agency because they see the boss doing this. And they think this is the way that it's done. And you get punished for not going along. But there's a hundred other mechanisms for agency capture. And those come from appropriations through the Congress.

And they want a soft landing at one of these companies. Mm-hmm. And their example then drives the – it infiltrates all the lower strata of the agency because they see the boss doing this. And they think this is the way that it's done. And you get punished for not going along. But there's a hundred other mechanisms for agency capture. And those come from appropriations through the Congress.

It comes from reactions to the press. All the major institutions of our society have been captured by the industry. The press now gets, you know, the mainstream television networks. And some Roger Ailes told me one time that 75% of his advertising revenues on the evening news divisions were pharmaceutical ads.

It comes from reactions to the press. All the major institutions of our society have been captured by the industry. The press now gets, you know, the mainstream television networks. And some Roger Ailes told me one time that 75% of his advertising revenues on the evening news divisions were pharmaceutical ads.

It comes from reactions to the press. All the major institutions of our society have been captured by the industry. The press now gets, you know, the mainstream television networks. And some Roger Ailes told me one time that 75% of his advertising revenues on the evening news divisions were pharmaceutical ads.

I mean, you can watch it. It's brought to you by Pfizer, brought to you by Pfizer.

I mean, you can watch it. It's brought to you by Pfizer, brought to you by Pfizer.

I mean, you can watch it. It's brought to you by Pfizer, brought to you by Pfizer.

You know, those companies are doing that partially because the evening news is very attractive to drug companies because Young people don't watch news. It's all older people. And those are their customers. They're people who are taking all this whole, you know, arsenal, this battery of drugs. But they also do it to control content.

You know, those companies are doing that partially because the evening news is very attractive to drug companies because Young people don't watch news. It's all older people. And those are their customers. They're people who are taking all this whole, you know, arsenal, this battery of drugs. But they also do it to control content.